tetrakis(8-(2,6-difluoro-4H-pyridin-4-id-3-yl)-2,3-dimethylimidazo[1,2-a]pyrazine);1-[4-(4,5-dimethyl-3-phenyl-2H-imidazol-2-id-1-yl)butyl]-4,5-dimethyl-3-phenyl-2H-imidazol-2-ide;tetrakis(iridium);1-phenyl-3-[4-(3-phenyl-2H-benzimidazol-2-id-1-yl)butyl]-2H-benzimidazol-2-ide;3-phenyl-1-[4-(3-phenyl-2H-imidazo[4,5-b]pyrazin-2-id-1-yl)butyl]-2H-imidazo[4,5-b]pyrazin-2-ide;3-phenyl-1-[4-(3-phenyl-2H-imidazo[4,5-b]pyridin-2-id-1-yl)butyl]-2H-imidazo[4,5-b]pyridin-2-ide

C162H138F8Ir4N38-20 — CID 160979728

IUPACtetrakis(8-(2,6-difluoro-4H-pyridin-4-id-3-yl)-2,3-dimethylimidazo[1,2-a]pyrazine);1-[4-(4,5-dimethyl-3-phenyl-2H-imidazol-2-id-1-yl)butyl]-4,5-dimethyl-3-phenyl-2H-imidazol-2-ide;tetrakis(iridium);1-phenyl-3-[4-(3-phenyl-2H-benzimidazol-2-id-1-yl)butyl]-2H-benzimidazol-2-ide;3-phenyl-1-[4-(3-phenyl-2H-imidazo[4,5-b]pyrazin-2-id-1-yl)butyl]-2H-imidazo[4,5-b]pyrazin-2-ide;3-phenyl-1-[4-(3-phenyl-2H-imidazo[4,5-b]pyridin-2-id-1-yl)butyl]-2H-imidazo[4,5-b]pyridin-2-ide
SMILESCC1=C(C)N(c2[c-]cccc2)[CH-]N1CCCCN1[CH-]N(c2[c-]cccc2)C(C)=C1C.Cc1nc2c(-c3[c-]cc(F)nc3F)nccn2c1C.Cc1nc2c(-c3[c-]cc(F)nc3F)nccn2c1C.Cc1nc2c(-c3[c-]cc(F)nc3F)nccn2c1C.Cc1nc2c(-c3[c-]cc(F)nc3F)nccn2c1C.[Ir].[Ir].[Ir].[Ir].[c-]1ccccc1N1[CH-]N(CCCCN2[CH-]N(c3[c-]cccc3)c3ccccc32)c2ccccc21.[c-]1ccccc1N1[CH-]N(CCCCN2[CH-]N(c3[c-]cccc3)c3ncccc32)c2cccnc21.[c-]1ccccc1N1[CH-]N(CCCCN2[CH-]N(c3[c-]cccc3)c3nccnc32)c2nccnc21
InChIInChI=1S/C30H26N4.C28H24N6.C26H22N8.C26H30N4.4C13H9F2N4.4Ir/c1-3-13-25(14-4-1)33-23-31(27-17-7-9-19-29(27)33)21-11-12-22-32-24-34(26-15-5-2-6-16-26)30-20-10-8-18-28(30)32;1-3-11-23(12-4-1)33-21-31(25-15-9-17-29-27(25)33)19-7-8-20-32-22-34(24-13-5-2-6-14-24)28-26(32)16-10-18-30-28;1-3-9-21(10-4-1)33-19-31(23-25(33)29-15-13-27-23)17-7-8-18-32-20-34(22-11-5-2-6-12-22)26-24(32)28-14-16-30-26;1-21-23(3)29(25-13-7-5-8-14-25)19-27(21)17-11-12-18-28-20-30(24(4)22(28)2)26-15-9-6-10-16-26;4*1-7-8(2)19-6-5-16-11(13(19)17-7)9-3-4-10(14)18-12(9)15;;;;/h1-10,13,15,17-20,23-24H,11-12,21-22H2;1-6,9-11,13,15-18,21-22H,7-8,19-20H2;1-6,9,11,13-16,19-20H,7-8,17-18H2;5-10,13,15,19-20H,11-12,17-18H2,1-4H3;4*4-6H,1-2H3;;;;/q4*-4;4*-1;;;;
InChIKeyGWHPLZSFUUFVNA-UHFFFAOYSA-N
MW3538.00 g/mol
LogP32.83
Rot. Bonds32

About tetrakis(8-(2,6-difluoro-4H-pyridin-4-id-3-yl)-2,3-dimethylimidazo[1,2-a]pyrazine);1-[4-(4,5-dimethyl-3-phenyl-2H-imidazol-2-id-1-yl)butyl]-4,5-dimethyl-3-phenyl-2H-imidazol-2-ide;tetrakis(iridium);1-phenyl-3-[4-(3-phenyl-2H-benzimidazol-2-id-1-yl)butyl]-2H-benzimidazol-2-ide;3-phenyl-1-[4-(3-phenyl-2H-imidazo[4,5-b]pyrazin-2-id-1-yl)butyl]-2H-imidazo[4,5-b]pyrazin-2-ide;3-phenyl-1-[4-(3-phenyl-2H-imidazo[4,5-b]pyridin-2-id-1-yl)butyl]-2H-imidazo[4,5-b]pyridin-2-ide

tetrakis(8-(2,6-difluoro-4H-pyridin-4-id-3-yl)-2,3-dimethylimidazo[1,2-a]pyrazine);1-[4-(4,5-dimethyl-3-phenyl-2H-imidazol-2-id-1-yl)butyl]-4,5-dimethyl-3-phenyl-2H-imidazol-2-ide;tetrakis(iridium);1-phenyl-3-[4-(3-phenyl-2H-benzimidazol-2-id-1-yl)butyl]-2H-benzimidazol-2-ide;3-phenyl-1-[4-(3-phenyl-2H-imidazo[4,5-b]pyrazin-2-id-1-yl)butyl]-2H-imidazo[4,5-b]pyrazin-2-ide;3-phenyl-1-[4-(3-phenyl-2H-imidazo[4,5-b]pyridin-2-id-1-yl)butyl]-2H-imidazo[4,5-b]pyridin-2-ide (PubChem CID 160979728) has the molecular formula C162H138F8Ir4N38-20 and a molecular weight of 3538.00 g/mol. Its IUPAC name is tetrakis(8-(2,6-difluoro-4H-pyridin-4-id-3-yl)-2,3-dimethylimidazo[1,2-a]pyrazine);1-[4-(4,5-dimethyl-3-phenyl-2H-imidazol-2-id-1-yl)butyl]-4,5-dimethyl-3-phenyl-2H-imidazol-2-ide;tetrakis(iridium);1-phenyl-3-[4-(3-phenyl-2H-benzimidazol-2-id-1-yl)butyl]-2H-benzimidazol-2-ide;3-phenyl-1-[4-(3-phenyl-2H-imidazo[4,5-b]pyrazin-2-id-1-yl)butyl]-2H-imidazo[4,5-b]pyrazin-2-ide;3-phenyl-1-[4-(3-phenyl-2H-imidazo[4,5-b]pyridin-2-id-1-yl)butyl]-2H-imidazo[4,5-b]pyridin-2-ide.

Molecular Properties

Compound Nametetrakis(8-(2,6-difluoro-4H-pyridin-4-id-3-yl)-2,3-dimethylimidazo[1,2-a]pyrazine);1-[4-(4,5-dimethyl-3-phenyl-2H-imidazol-2-id-1-yl)butyl]-4,5-dimethyl-3-phenyl-2H-imidazol-2-ide;tetrakis(iridium);1-phenyl-3-[4-(3-phenyl-2H-benzimidazol-2-id-1-yl)butyl]-2H-benzimidazol-2-ide;3-phenyl-1-[4-(3-phenyl-2H-imidazo[4,5-b]pyrazin-2-id-1-yl)butyl]-2H-imidazo[4,5-b]pyrazin-2-ide;3-phenyl-1-[4-(3-phenyl-2H-imidazo[4,5-b]pyridin-2-id-1-yl)butyl]-2H-imidazo[4,5-b]pyridin-2-ide
PubChem CID160979728
Molecular FormulaC162H138F8Ir4N38-20
Molecular Weight3538.00 g/mol
Exact Mass3539.05
IUPAC Nametetrakis(8-(2,6-difluoro-4H-pyridin-4-id-3-yl)-2,3-dimethylimidazo[1,2-a]pyrazine);1-[4-(4,5-dimethyl-3-phenyl-2H-imidazol-2-id-1-yl)butyl]-4,5-dimethyl-3-phenyl-2H-imidazol-2-ide;tetrakis(iridium);1-phenyl-3-[4-(3-phenyl-2H-benzimidazol-2-id-1-yl)butyl]-2H-benzimidazol-2-ide;3-phenyl-1-[4-(3-phenyl-2H-imidazo[4,5-b]pyrazin-2-id-1-yl)butyl]-2H-imidazo[4,5-b]pyrazin-2-ide;3-phenyl-1-[4-(3-phenyl-2H-imidazo[4,5-b]pyridin-2-id-1-yl)butyl]-2H-imidazo[4,5-b]pyridin-2-ide
SMILESCC1=C(C)N(c2[c-]cccc2)[CH-]N1CCCCN1[CH-]N(c2[c-]cccc2)C(C)=C1C.Cc1nc2c(-c3[c-]cc(F)nc3F)nccn2c1C.Cc1nc2c(-c3[c-]cc(F)nc3F)nccn2c1C.Cc1nc2c(-c3[c-]cc(F)nc3F)nccn2c1C.Cc1nc2c(-c3[c-]cc(F)nc3F)nccn2c1C.[Ir].[Ir].[Ir].[Ir].[c-]1ccccc1N1[CH-]N(CCCCN2[CH-]N(c3[c-]cccc3)c3ccccc32)c2ccccc21.[c-]1ccccc1N1[CH-]N(CCCCN2[CH-]N(c3[c-]cccc3)c3ncccc32)c2cccnc21.[c-]1ccccc1N1[CH-]N(CCCCN2[CH-]N(c3[c-]cccc3)c3nccnc32)c2nccnc21
InChIInChI=1S/C30H26N4.C28H24N6.C26H22N8.C26H30N4.4C13H9F2N4.4Ir/c1-3-13-25(14-4-1)33-23-31(27-17-7-9-19-29(27)33)21-11-12-22-32-24-34(26-15-5-2-6-16-26)30-20-10-8-18-28(30)32;1-3-11-23(12-4-1)33-21-31(25-15-9-17-29-27(25)33)19-7-8-20-32-22-34(24-13-5-2-6-14-24)28-26(32)16-10-18-30-28;1-3-9-21(10-4-1)33-19-31(23-25(33)29-15-13-27-23)17-7-8-18-32-20-34(22-11-5-2-6-12-22)26-24(32)28-14-16-30-26;1-21-23(3)29(25-13-7-5-8-14-25)19-27(21)17-11-12-18-28-20-30(24(4)22(28)2)26-15-9-6-10-16-26;4*1-7-8(2)19-6-5-16-11(13(19)17-7)9-3-4-10(14)18-12(9)15;;;;/h1-10,13,15,17-20,23-24H,11-12,21-22H2;1-6,9-11,13,15-18,21-22H,7-8,19-20H2;1-6,9,11,13-16,19-20H,7-8,17-18H2;5-10,13,15,19-20H,11-12,17-18H2,1-4H3;4*4-6H,1-2H3;;;;/q4*-4;4*-1;;;;
InChIKeyGWHPLZSFUUFVNA-UHFFFAOYSA-N
XLogP32.83
TPSA301.50 Ų
H-Bond Donors
H-Bond Acceptors38
Rotatable Bonds32
Heavy Atoms212
Complexity—

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5003538.00
LogP ≤ 532.83
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 1038

Computed Properties (RDKit)

Structural Alerts{'alert_name': '2-halo_pyridine', 'substructure': 'N/A'}, {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'Carbo_cation/anion', 'substructure': 'N/A'}

Analyze tetrakis(8-(2,6-difluoro-4H-pyridin-4-id-3-yl)-2,3-dimethylimidazo[1,2-a]pyrazine);1-[4-(4,5-dimethyl-3-phenyl-2H-imidazol-2-id-1-yl)butyl]-4,5-dimethyl-3-phenyl-2H-imidazol-2-ide;tetrakis(iridium);1-phenyl-3-[4-(3-phenyl-2H-benzimidazol-2-id-1-yl)butyl]-2H-benzimidazol-2-ide;3-phenyl-1-[4-(3-phenyl-2H-imidazo[4,5-b]pyrazin-2-id-1-yl)butyl]-2H-imidazo[4,5-b]pyrazin-2-ide;3-phenyl-1-[4-(3-phenyl-2H-imidazo[4,5-b]pyridin-2-id-1-yl)butyl]-2H-imidazo[4,5-b]pyridin-2-ide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

2,3-dimethyl-8-phenylimidazo[1,2-a]pyrazine;1-[4-[4,5-dimethyl-3-(4-propan-2-ylbenzene-6-id-1-yl)-2H-imidazol-2-id-1-yl]butyl]-4,5-dimethyl-3-(4-propan-2-ylbenzene-6-id-1-yl)-2H-imidazol-2-ide;iridium
CID 155636954
iridium;1-methyl-3-phenyl-2H-imidazo[4,5-b]pyridin-2-ide;1-phenyl-3-[4-(3-phenyl-2H-benzimidazol-2-id-1-yl)butyl]-2H-benzimidazol-2-ide
CID 155625565
3-(2,4-difluorobenzene-6-id-1-yl)-1-methyl-2H-imidazo[4,5-b]pyrazin-2-ide;iridium;3-phenyl-1-[4-(3-phenyl-2H-imidazo[4,5-b]pyrazin-2-id-1-yl)butyl]-2H-imidazo[4,5-b]pyrazin-2-ide
CID 155625583
1-[4-(4,5-dimethyl-3-phenyl-2H-imidazol-2-id-1-yl)butyl]-4,5-dimethyl-3-phenyl-2H-imidazol-2-ide;bis(iridium);bis(1-methyl-3-(4H-pyridin-4-id-3-yl)-2H-imidazo[4,5-b]pyrazin-2-ide);1-phenyl-3-[4-(3-phenyl-2H-imidazol-2-id-1-yl)butyl]-2H-imidazol-2-ide
CID 160590198
3-(4-tert-butylbenzene-6-id-1-yl)-1-(2-methylphenyl)-2H-imidazo[4,5-b]pyridin-2-ide;tetrakis(iridium);1-(2-methylphenyl)-3-phenyl-2H-benzimidazol-2-ide;3-(2-methylphenyl)-1-phenyl-2H-imidazo[4,5-b]pyrazin-2-ide;3-(2-methylphenyl)-1-phenyl-2H-imidazo[4,5-b]pyridin-2-ide
CID 159417650
2-[3-[4-[4,5-dimethyl-3-(3H-pyridin-3-id-2-yl)-2H-imidazol-2-id-1-yl]butyl]-4,5-dimethyl-2H-imidazol-2-id-1-yl]-3H-pyridin-3-ide;tetrakis(iridium);tetrakis(1-methyl-3-(3-propan-2-ylbenzene-6-id-1-yl)-2H-imidazo[4,5-b]pyrazin-2-ide);2-[3-[4-[3-(3H-pyridin-3-id-2-yl)-2H-imidazol-2-id-1-yl]butyl]-2H-imidazol-2-id-1-yl]-3H-pyridin-3-ide;1-(3H-pyridin-3-id-2-yl)-3-[4-[3-(3H-pyridin-3-id-2-yl)-2H-benzimidazol-2-id-1-yl]butyl]-2H-benzimidazol-2-ide;3-(3H-pyridin-3-id-2-yl)-1-[4-[3-(3H-pyridin-3-id-2-yl)-2H-imidazo[4,5-b]pyridin-2-id-1-yl]butyl]-2H-imidazo[4,5-b]pyridin-2-ide
CID 158092577
1-[4-(4,5-dimethyl-3-phenyl-2H-imidazol-2-id-1-yl)butyl]-4,5-dimethyl-3-phenyl-2H-imidazol-2-ide;bis(iridium);bis(1-methyl-3-(3-propan-2-ylbenzene-6-id-1-yl)-2H-imidazo[4,5-b]pyrazin-2-ide);1-phenyl-3-[4-(3-phenyl-2H-imidazol-2-id-1-yl)butyl]-2H-imidazol-2-ide
CID 159180957
iridium;1-methyl-3-phenyl-2H-imidazo[4,5-b]pyrazin-2-ide;1-phenyl-3-phenyl-2H-benzimidazol-2-ide
CID 58556265
2-(3H-dibenzofuran-3-id-4-yl)pyridine;iridium;1-phenyl-3-[4-(3-phenyl-2H-benzimidazol-2-id-1-yl)butyl]-2H-benzimidazol-2-ide
CID 155607516
bis(1-methyl-3-phenyl-2H-imidazo[4,5-b]pyrazin-2-ide);platinum;bis(pyrido[2,3-b]indol-9-ide)
CID 176621912
1,5-bis(2-methylphenyl)-3-phenyl-2H-benzimidazol-2-ide;tris(iridium);1-phenyl-3-(2-phenylphenyl)-2H-imidazo[4,5-b]pyridin-2-ide;3-phenyl-1-(2-phenylphenyl)-2H-imidazo[4,5-b]pyridin-2-ide
CID 158893903
bis(4-tert-butyl-2-[4-[4-tert-butyl-6-(2,4-difluorobenzene-6-id-1-yl)-2-pyridinyl]butyl]-6-(2,4-difluorobenzene-6-id-1-yl)pyridine);4-tert-butyl-2-[4-[4-tert-butyl-6-(4-fluorobenzene-6-id-1-yl)-2-pyridinyl]butyl]-6-(4-fluorobenzene-6-id-1-yl)pyridine;2-(2,4-difluorobenzene-6-id-1-yl)-6-[4-[6-(2,4-difluorobenzene-6-id-1-yl)-4-methyl-2-pyridinyl]butyl]-4-methylpyridine;tetrakis(iridium);tris(1-methyl-3-phenyl-2H-benzimidazol-2-ide);1,4,5-trimethyl-3-phenyl-2H-imidazol-2-ide
CID 162035749

Frequently Asked Questions

What is the IUPAC name of tetrakis(8-(2,6-difluoro-4H-pyridin-4-id-3-yl)-2,3-dimethylimidazo[1,2-a]pyrazine);1-[4-(4,5-dimethyl-3-phenyl-2H-imidazol-2-id-1-yl)butyl]-4,5-dimethyl-3-phenyl-2H-imidazol-2-ide;tetrakis(iridium);1-phenyl-3-[4-(3-phenyl-2H-benzimidazol-2-id-1-yl)butyl]-2H-benzimidazol-2-ide;3-phenyl-1-[4-(3-phenyl-2H-imidazo[4,5-b]pyrazin-2-id-1-yl)butyl]-2H-imidazo[4,5-b]pyrazin-2-ide;3-phenyl-1-[4-(3-phenyl-2H-imidazo[4,5-b]pyridin-2-id-1-yl)butyl]-2H-imidazo[4,5-b]pyridin-2-ide?
The IUPAC name of tetrakis(8-(2,6-difluoro-4H-pyridin-4-id-3-yl)-2,3-dimethylimidazo[1,2-a]pyrazine);1-[4-(4,5-dimethyl-3-phenyl-2H-imidazol-2-id-1-yl)butyl]-4,5-dimethyl-3-phenyl-2H-imidazol-2-ide;tetrakis(iridium);1-phenyl-3-[4-(3-phenyl-2H-benzimidazol-2-id-1-yl)butyl]-2H-benzimidazol-2-ide;3-phenyl-1-[4-(3-phenyl-2H-imidazo[4,5-b]pyrazin-2-id-1-yl)butyl]-2H-imidazo[4,5-b]pyrazin-2-ide;3-phenyl-1-[4-(3-phenyl-2H-imidazo[4,5-b]pyridin-2-id-1-yl)butyl]-2H-imidazo[4,5-b]pyridin-2-ide (CID 160979728) is tetrakis(8-(2,6-difluoro-4H-pyridin-4-id-3-yl)-2,3-dimethylimidazo[1,2-a]pyrazine);1-[4-(4,5-dimethyl-3-phenyl-2H-imidazol-2-id-1-yl)butyl]-4,5-dimethyl-3-phenyl-2H-imidazol-2-ide;tetrakis(iridium);1-phenyl-3-[4-(3-phenyl-2H-benzimidazol-2-id-1-yl)butyl]-2H-benzimidazol-2-ide;3-phenyl-1-[4-(3-phenyl-2H-imidazo[4,5-b]pyrazin-2-id-1-yl)butyl]-2H-imidazo[4,5-b]pyrazin-2-ide;3-phenyl-1-[4-(3-phenyl-2H-imidazo[4,5-b]pyridin-2-id-1-yl)butyl]-2H-imidazo[4,5-b]pyridin-2-ide.
What is the SMILES notation for tetrakis(8-(2,6-difluoro-4H-pyridin-4-id-3-yl)-2,3-dimethylimidazo[1,2-a]pyrazine);1-[4-(4,5-dimethyl-3-phenyl-2H-imidazol-2-id-1-yl)butyl]-4,5-dimethyl-3-phenyl-2H-imidazol-2-ide;tetrakis(iridium);1-phenyl-3-[4-(3-phenyl-2H-benzimidazol-2-id-1-yl)butyl]-2H-benzimidazol-2-ide;3-phenyl-1-[4-(3-phenyl-2H-imidazo[4,5-b]pyrazin-2-id-1-yl)butyl]-2H-imidazo[4,5-b]pyrazin-2-ide;3-phenyl-1-[4-(3-phenyl-2H-imidazo[4,5-b]pyridin-2-id-1-yl)butyl]-2H-imidazo[4,5-b]pyridin-2-ide?
The canonical SMILES for tetrakis(8-(2,6-difluoro-4H-pyridin-4-id-3-yl)-2,3-dimethylimidazo[1,2-a]pyrazine);1-[4-(4,5-dimethyl-3-phenyl-2H-imidazol-2-id-1-yl)butyl]-4,5-dimethyl-3-phenyl-2H-imidazol-2-ide;tetrakis(iridium);1-phenyl-3-[4-(3-phenyl-2H-benzimidazol-2-id-1-yl)butyl]-2H-benzimidazol-2-ide;3-phenyl-1-[4-(3-phenyl-2H-imidazo[4,5-b]pyrazin-2-id-1-yl)butyl]-2H-imidazo[4,5-b]pyrazin-2-ide;3-phenyl-1-[4-(3-phenyl-2H-imidazo[4,5-b]pyridin-2-id-1-yl)butyl]-2H-imidazo[4,5-b]pyridin-2-ide is CC1=C(C)N(c2[c-]cccc2)[CH-]N1CCCCN1[CH-]N(c2[c-]cccc2)C(C)=C1C.Cc1nc2c(-c3[c-]cc(F)nc3F)nccn2c1C.Cc1nc2c(-c3[c-]cc(F)nc3F)nccn2c1C.Cc1nc2c(-c3[c-]cc(F)nc3F)nccn2c1C.Cc1nc2c(-c3[c-]cc(F)nc3F)nccn2c1C.[Ir].[Ir].[Ir].[Ir].[c-]1ccccc1N1[CH-]N(CCCCN2[CH-]N(c3[c-]cccc3)c3ccccc32)c2ccccc21.[c-]1ccccc1N1[CH-]N(CCCCN2[CH-]N(c3[c-]cccc3)c3ncccc32)c2cccnc21.[c-]1ccccc1N1[CH-]N(CCCCN2[CH-]N(c3[c-]cccc3)c3nccnc32)c2nccnc21.
What is the InChIKey of tetrakis(8-(2,6-difluoro-4H-pyridin-4-id-3-yl)-2,3-dimethylimidazo[1,2-a]pyrazine);1-[4-(4,5-dimethyl-3-phenyl-2H-imidazol-2-id-1-yl)butyl]-4,5-dimethyl-3-phenyl-2H-imidazol-2-ide;tetrakis(iridium);1-phenyl-3-[4-(3-phenyl-2H-benzimidazol-2-id-1-yl)butyl]-2H-benzimidazol-2-ide;3-phenyl-1-[4-(3-phenyl-2H-imidazo[4,5-b]pyrazin-2-id-1-yl)butyl]-2H-imidazo[4,5-b]pyrazin-2-ide;3-phenyl-1-[4-(3-phenyl-2H-imidazo[4,5-b]pyridin-2-id-1-yl)butyl]-2H-imidazo[4,5-b]pyridin-2-ide?
The InChIKey is GWHPLZSFUUFVNA-UHFFFAOYSA-N. The full InChI is InChI=1S/C30H26N4.C28H24N6.C26H22N8.C26H30N4.4C13H9F2N4.4Ir/c1-3-13-25(14-4-1)33-23-31(27-17-7-9-19-29(27)33)21-11-12-22-32-24-34(26-15-5-2-6-16-26)30-20-10-8-18-28(30)32;1-3-11-23(12-4-1)33-21-31(25-15-9-17-29-27(25)33)19-7-8-20-32-22-34(24-13-5-2-6-14-24)28-26(32)16-10-18-30-28;1-3-9-21(10-4-1)33-19-31(23-25(33)29-15-13-27-23)17-7-8-18-32-20-34(22-11-5-2-6-12-22)26-24(32)28-14-16-30-26;1-21-23(3)29(25-13-7-5-8-14-25)19-27(21)17-11-12-18-28-20-30(24(4)22(28)2)26-15-9-6-10-16-26;4*1-7-8(2)19-6-5-16-11(13(19)17-7)9-3-4-10(14)18-12(9)15;;;;/h1-10,13,15,17-20,23-24H,11-12,21-22H2;1-6,9-11,13,15-18,21-22H,7-8,19-20H2;1-6,9,11,13-16,19-20H,7-8,17-18H2;5-10,13,15,19-20H,11-12,17-18H2,1-4H3;4*4-6H,1-2H3;;;;/q4*-4;4*-1;;;;.
What are the key properties of tetrakis(8-(2,6-difluoro-4H-pyridin-4-id-3-yl)-2,3-dimethylimidazo[1,2-a]pyrazine);1-[4-(4,5-dimethyl-3-phenyl-2H-imidazol-2-id-1-yl)butyl]-4,5-dimethyl-3-phenyl-2H-imidazol-2-ide;tetrakis(iridium);1-phenyl-3-[4-(3-phenyl-2H-benzimidazol-2-id-1-yl)butyl]-2H-benzimidazol-2-ide;3-phenyl-1-[4-(3-phenyl-2H-imidazo[4,5-b]pyrazin-2-id-1-yl)butyl]-2H-imidazo[4,5-b]pyrazin-2-ide;3-phenyl-1-[4-(3-phenyl-2H-imidazo[4,5-b]pyridin-2-id-1-yl)butyl]-2H-imidazo[4,5-b]pyridin-2-ide?
tetrakis(8-(2,6-difluoro-4H-pyridin-4-id-3-yl)-2,3-dimethylimidazo[1,2-a]pyrazine);1-[4-(4,5-dimethyl-3-phenyl-2H-imidazol-2-id-1-yl)butyl]-4,5-dimethyl-3-phenyl-2H-imidazol-2-ide;tetrakis(iridium);1-phenyl-3-[4-(3-phenyl-2H-benzimidazol-2-id-1-yl)butyl]-2H-benzimidazol-2-ide;3-phenyl-1-[4-(3-phenyl-2H-imidazo[4,5-b]pyrazin-2-id-1-yl)butyl]-2H-imidazo[4,5-b]pyrazin-2-ide;3-phenyl-1-[4-(3-phenyl-2H-imidazo[4,5-b]pyridin-2-id-1-yl)butyl]-2H-imidazo[4,5-b]pyridin-2-ide has a molecular weight of 3538.00 g/mol, XLogP of 32.83, 32 rotatable bonds, 0 hydrogen bond donors, and 38 hydrogen bond acceptors.
Where does this data come from?
All data for tetrakis(8-(2,6-difluoro-4H-pyridin-4-id-3-yl)-2,3-dimethylimidazo[1,2-a]pyrazine);1-[4-(4,5-dimethyl-3-phenyl-2H-imidazol-2-id-1-yl)butyl]-4,5-dimethyl-3-phenyl-2H-imidazol-2-ide;tetrakis(iridium);1-phenyl-3-[4-(3-phenyl-2H-benzimidazol-2-id-1-yl)butyl]-2H-benzimidazol-2-ide;3-phenyl-1-[4-(3-phenyl-2H-imidazo[4,5-b]pyrazin-2-id-1-yl)butyl]-2H-imidazo[4,5-b]pyrazin-2-ide;3-phenyl-1-[4-(3-phenyl-2H-imidazo[4,5-b]pyridin-2-id-1-yl)butyl]-2H-imidazo[4,5-b]pyridin-2-ide is sourced from PubChem (CID 160979728), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).